Attrition Rates High Among Lesbian, Gay, Bisexual Medical Students
By Lori Solomon HealthDay Reporter
WEDNESDAY, June 11, 2025 -- Medical school attrition rates are high among lesbian, gay, or bisexual (LGB) medical students, according to a research letter published online June 10 in JAMA Network Open.
Mytien Nguyen, from the Yale School of Medicine in New Haven, Connecticut, and colleagues examined attrition rates at the intersection of sexual orientation, race, ethnicity, and sex among a national cohort of medical students. The analysis included 2014 to 2017 data from the Association of American Medical Colleges data warehouse (83,342 matriculants and 56,031 respondents to the Matriculating Student Questionnaire [MSQ]).
The researchers found that attrition rates were higher among MSQ nonrespondents (3.8 versus 2.6 percent). Complete demographic data were available for 80.8 percent of respondents (51 percent female; 19 percent identifying as Asian, 6.2 percent as Black, 6.2 percent as Hispanic, 57.9 percent as White, and 10.5 percent as other race and ethnicity; 6.3 percent identified as LGB). Overall, 2.5 percent of matriculants left school. A higher proportion of bisexual (4.2 versus 2.4 percent; adjusted odds ratio [aOR], 1.99) and gay and lesbian (3.7 versus 2.4 percent; aOR, 1.47) students left school compared with non-LGB students. When adjusting for Medical College Admission Test scores, non-LGB Asian, Black, and Hispanic male; LGB White female; and LGB Hispanic male and female students were more likely to leave school compared with non-LGB White students. The highest odds of attrition were seen among LGB Hispanic male and female students (aORs, 3.11 and 3.52, respectively).
“Examining medical school attrition rates among marginalized identities and contextualized experiences at the intersection of these identities is essential to developing support services that empower student success,” the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-06-12 06:00
Read more

- Kura Oncology and Kyowa Kirin Announce Submission of New Drug Application for Ziftomenib to FDA
- Maternal Obesity Linked to Pediatric Hospital Admissions for Infection
- NIH Scientists Pioneer Promising Treatment for Intractable Cancer Pain
- FDA Issues Highest Alert Over Tomato Recall in 3 Southern States
- Coffee Could Be Key To Aging Gracefully
- Sedentary Behavior in U.S. Adults Declined in Last Decade
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions